Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

AcelRx Pharmaceuticals (ACRX)

Add to Watchlists
Create an Alert
10.89 -0.63  -5.47% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
ACRX Price Chart
View All Events

ACRX Events

Date Type Description
Mar 03 Misc AcelRx Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Mar 03 Earnings AcelRx Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -0.18.
Nov 05 Misc AcelRx Pharmaceuticals, Inc. Q3 2013 Earnings Conference Call
Nov 05 Earnings AcelRx Pharmaceuticals, Inc. Q3 2013 Earnings Release. Estimate: -0.18.
Aug 12 Misc Q2 2013 AcelRx Pharmaceuticals, Inc. Earnings Conference Call
Aug 12 Earnings AcelRx Pharmaceuticals Announces Second Quarter 2013 Financial Results. Estimate: -0.25.
May 08 Misc Q1 2013 AcelRx Pharmaceuticals, Inc. Earnings Conference Call
May 08 Earnings Q1 2013 AcelRx Pharmaceuticals, Inc. Earnings Conference Call and Result. Estimate: -0.22.
View All Performance Charts

ACRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AcelRx Pharmaceuticals is up 84.89% over the last year vs S&P 500 Total Return up 22.59%, Amedica up N/A, and NuVasive up 67.95%.

Get Quote for

PDF Report for ACRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ACRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring ACRX

Did AcelRx Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ACRX Profile

  • Sector: Healthcare
  • Industry: Medical Devices
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Surgical and Medical Instrument Manufacturing
  • NAICS Code: 339112
  • NAICS Industry: Medical Equipment and Supplies Manufacturing
  • NAICS Industry Code: 3391
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 33

AcelRx Pharmaceuticals, Inc. is a development stage company, which is engaged in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ACRX 10.89 -0.63 -5.47% 470.25M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.